Published in PLoS One on January 17, 2017
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 18.52
Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest (1993) 10.09
The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol (2008) 7.91
The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe (2014) 7.43
Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A (2006) 5.19
Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest (2004) 5.14
Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell (2014) 4.25
Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol (2005) 4.01
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest (2002) 3.21
Liver: An organ with predominant innate immunity. Hepatology (2008) 3.13
Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology (2012) 2.62
Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis. Hepatology (2010) 2.48
Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology (2013) 2.42
Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology (2010) 2.30
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut (2011) 2.06
Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology (2010) 1.82
Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology (2000) 1.75
NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature (2016) 1.71
Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis. J Immunol (2013) 1.67
Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology (1995) 1.60
Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon. PLoS One (2012) 1.56
Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol (2003) 1.55
Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J Pathol (2006) 1.46
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut (2012) 1.46
Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology (2003) 1.45
Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J Immunol (2008) 1.40
Home parenteral nutrition: the first twelve months. Scott Med J (1982) 1.40
Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Proc Natl Acad Sci U S A (2012) 1.35
NK and NKT cells in liver injury and fibrosis. Clin Immunol (2008) 1.35
Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio (2015) 1.26
Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis. Curr Opin Lipidol (2008) 1.24
Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. PLoS One (2012) 1.21
Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol (2012) 1.17
Stress signaling in the methionine-choline-deficient model of murine fatty liver disease. Gastroenterology (2010) 1.13
Existing dietary guidelines for Crohn's disease and ulcerative colitis. Expert Rev Gastroenterol Hepatol (2011) 1.09
Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. Magn Reson Imaging (2008) 1.03
Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response. Immunity (2015) 1.02
Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice. Inflamm Bowel Dis (2005) 1.02
Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease. Gut (2009) 1.01
Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochem Biophys Res Commun (2008) 0.96
dysregulation of CD1d-restricted type ii natural killer T cells leads to spontaneous development of colitis in mice. Gastroenterology (2011) 0.96
IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis. Gut (2014) 0.93
Sensing environmental lipids by dendritic cell modulates its function. J Immunol (2004) 0.92
Serum metabolic profiling in inflammatory bowel disease. Dig Dis Sci (2012) 0.91
Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model. Am J Physiol Gastrointest Liver Physiol (2013) 0.89
Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease. J Immunol (2014) 0.88
Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding. PLoS One (2014) 0.88
Review article: evidence-based dietary advice for patients with inflammatory bowel disease. Aliment Pharmacol Ther (2013) 0.87
Flexible colonoscopy in mice to evaluate the severity of colitis and colorectal tumors using a validated endoscopic scoring system. J Vis Exp (2013) 0.87
Exosome-like nanoparticles from intestinal mucosal cells carry prostaglandin E2 and suppress activation of liver NKT cells. J Immunol (2013) 0.86
NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses. Clin Sci (Lond) (2013) 0.86
IL-9-producing invariant NKT cells protect against DSS-induced colitis in an IL-4-dependent manner. Mucosal Immunol (2012) 0.85
Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases. World J Gastroenterol (2014) 0.85
Deficiency of invariant NK T cells in Crohn's disease and ulcerative colitis. Dig Dis Sci (2007) 0.85
Analyzing antigen recognition by Natural Killer T cells. Methods Mol Biol (2013) 0.83
Activation of prostaglandin E2-EP4 signaling reduces chemokine production in adipose tissue. J Lipid Res (2014) 0.81
The induction of resistant hepatocytes during initiation of liver carcinogenesis with chemicals in rats fed a choline deficient methionine low diet. Carcinogenesis (1983) 0.80
Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma. Cancer Sci (2016) 0.79
Immune response in mouse experimental cholangitis associated with colitis induced by dextran sulfate sodium. J Gastroenterol Hepatol (2004) 0.79
EP4 Receptor-Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated Tumorigenesis. PLoS Genet (2015) 0.78
Stool phospholipid signature is altered by diet and tumors. PLoS One (2014) 0.78
Antagonist of prostaglandin E2 receptor 4 induces metabolic alterations in liver of mice. J Proteome Res (2015) 0.78
Estimation of choline intake from 24 h dietary intake recalls and contribution of egg and milk consumption to intake among pregnant and lactating women in Alberta. Br J Nutr (2014) 0.77
NKT cells mediate the recruitment of neutrophils by stimulating epithelial chemokine secretion during colitis. Biochem Biophys Res Commun (2016) 0.76
Significance of non-alcoholic fatty liver disease in Crohn's disease: A retrospective cohort study. Hepatol Res (2016) 0.76
Endoscopic submucosal dissection for colorectal neoplasia: possibility of standardization. Gastrointest Endosc (2007) 2.62
Feasibility of a novel colonoscope with extra-wide angle of view: a clinical study. Endoscopy (2014) 1.42
Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Am J Gastroenterol (2015) 1.05
Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice. Inflamm Bowel Dis (2005) 1.02
Endoscopic assessment of colorectal cancer with superficial or deep submucosal invasion using magnifying colonoscopy. Clin Endosc (2013) 0.95
mTOR and PDGF pathway blockade inhibits liver metastasis of colorectal cancer by modulating the tumor microenvironment. Am J Pathol (2014) 0.90
Predictors of incomplete resection and perforation associated with endoscopic submucosal dissection for colorectal tumors. Gastrointest Endosc (2013) 0.90
Towards safer and appropriate application of endoscopic submucosal dissection for T1 colorectal carcinoma as total excisional biopsy: future perspectives. Dig Endosc (2014) 0.88
Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B. Dig Dis Sci (2005) 0.88
Clinical outcomes of endoscopic submucosal dissection for superficial Barrett's adenocarcinoma. Gastrointest Endosc (2014) 0.87
Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels. J Gastroenterol Hepatol (2015) 0.86
Evaluation of the clinical efficacy of colon capsule endoscopy in the detection of lesions of the colon: prospective, multicenter, open study. Gastrointest Endosc (2015) 0.86
Risk factors for esophageal stenosis after entire circumferential endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Surg Endosc (2015) 0.85
Time Trends in Helicobacter pylori Infection and Atrophic Gastritis Over 40 Years in Japan. Helicobacter (2015) 0.84
Critical role of exogenous nitric oxide in ROCK activity in vascular smooth muscle cells. PLoS One (2014) 0.83
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol (2017) 0.82
Combining molecular targeted drugs to inhibit both cancer cells and activated stromal cells in gastric cancer. Neoplasia (2013) 0.81
Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma. Cancer Sci (2016) 0.79
Efficacy of probucol for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label pilot study. Hepatol Res (2013) 0.79
Infliximab treatment for Crohn's disease in a patient with IgA nephropathy. Clin J Gastroenterol (2009) 0.78
Early squamous cell carcinoma of the anal canal resected by endoscopic submucosal dissection. Case Rep Gastroenterol (2015) 0.78
Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation. PLoS One (2016) 0.77
ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma. Cancer Med (2016) 0.77
The Asia-Pacific Colorectal Screening Score Is Useful To Stratify Risk for Colorectal Advanced Neoplasms in Vietnamese Patients with Irritable Bowel Syndrome. J Gastroenterol Hepatol (2017) 0.77
Significance of non-alcoholic fatty liver disease in Crohn's disease: A retrospective cohort study. Hepatol Res (2016) 0.76
Two Cases of Severe Ulcerative Colitis with Colonic Dilatation Resolved with Tacrolimus Therapy. Case Rep Gastroenterol (2015) 0.75
Clinical impact of dual red imaging in colorectal endoscopic submucosal dissection: a pilot study. Therap Adv Gastroenterol (2016) 0.75
Clinicopathologic characteristics and management of minute esophageal lesions diagnosed by narrow-band imaging endoscopy. Endosc Int Open (2016) 0.75
Clinical usefulness of narrow band imaging magnifying colonoscopy for assessing ulcerative colitis-associated cancer/dysplasia. Endosc Int Open (2016) 0.75
Early Diagnosis of Helicobacter pylori Infection in Vietnamese Patients with Acute Peptic Ulcer Bleeding: A Prospective Study. Gastroenterol Res Pract (2017) 0.75
Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study. Biomed Res Int (2015) 0.75
Useful condition of chromoendoscopy with indigo carmine and acetic acid for identifying a demarcation line prior to endoscopic submucosal dissection for early gastric cancer. BMC Gastroenterol (2016) 0.75
Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study. Gastric Cancer (2016) 0.75
Clinical significance of small-bowel villous edema in patients with liver cirrhosis-a capsule endoscopy study. J Gastroenterol Hepatol (2017) 0.75
Associations between drugs and small-bowel mucosal bleeding: A multicenter capsule-endoscopy study. Dig Endosc (2017) 0.75
Clinical impact of surveillance colonoscopy using magnification without diminutive polyp removal. Dig Endosc (2017) 0.75
Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey. J Gastroenterol (2019) 0.75
Diagnostic performance of Japan NBI Expert Team classification for differentiation among noninvasive, superficially invasive, and deeply invasive colorectal neoplasia. Gastrointest Endosc (2017) 0.75
Prevention and management of spouting bleeding during endoscopic submucosal dissection for large subpedunculated type colonic tumor. Dig Endosc (2017) 0.75
Clinical impact and characteristics of the narrow-band imaging magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Gastrointest Endosc (2016) 0.75
Efficacy of ecabet sodium enema on intractable rectal ulcer after piecemeal endoscopic mucosal resection for rectal tumor. Clin J Gastroenterol (2010) 0.75
Proton pump inhibitor therapy did not increase the prevalence of small-bowel injury: A propensity-matched analysis. PLoS One (2017) 0.75
Indications and outcomes of colorectal hybrid endoscopic submucosal dissection: a large multicenter 10-year study. Surg Endosc (2021) 0.75
Long-term outcomes after treatment for pedunculated-type T1 colorectal carcinoma: a multicenter retrospective cohort study. J Gastroenterol (2015) 0.75
Endoscopic hemostasis for spurting duodenal bleeding using dual red imaging. Dig Endosc (2017) 0.75
Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group. J Gastroenterol (2017) 0.75
Advanced diagnostic endoscopy in lower GI: A review of JGES Core Sessions. Dig Endosc (2017) 0.75
Long-term outcomes after treatment for T1 colorectal carcinoma. Int J Colorectal Dis (2015) 0.75
Clinical significance and validity of the subclassification for colorectal laterally spreading tumor granular type. J Gastroenterol Hepatol (2016) 0.75
Long-term outcomes after endoscopic submucosal dissection for superficial colorectal tumors. Gastrointest Endosc (2016) 0.75
Mesalazine-induced enteritis causing refractory diarrhea. Dig Endosc (2016) 0.75
Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradiation therapy. J Gastroenterol (2019) 0.75
Endoscopic subtypes of colorectal laterally spreading tumors (LSTs) and the risk of submucosal invasion: a meta-analysis. Endoscopy (2017) 0.75
Polyglycolic acid sheet application for intractable acute hemorrhagic rectal ulcer. Dig Endosc (2016) 0.75
Preceding endoscopic submucosal dissection for T1 colorectal carcinoma does not affect the prognosis of patients who underwent additional surgery: a large multicenter propensity score-matched analysis. J Gastroenterol (2019) 0.75
Clinical Usefulness of the VS Classification System Using Magnifying Endoscopy with Blue Laser Imaging for Early Gastric Cancer. Gastroenterol Res Pract (2017) 0.75
Rapid progression of Epstein-Barr-virus-positive gastric diffuse large B-cell lymphoma during chemoradiotherapy: a case report. Clin J Gastroenterol (2008) 0.75
Clinicopathological characteristics of colorectal serrated polyposis syndrome (SPS): results of a multicenter study by the SPS Study Group in Japan. J Gastroenterol (2022) 0.75
Clinicopathologic and endoscopic features of early-stage colorectal serrated adenocarcinoma. BMC Gastroenterol (2017) 0.75
Cheilitis granulomatosa as an early manifestation of Crohn's disease. Clin J Gastroenterol (2009) 0.75
Pedunculated-type T1 colorectal carcinoma with lung carcinoma metastasis at the deepest invasive portion. Clin J Gastroenterol (2016) 0.75
Diagnostic Accuracy of Status by Conventional Endoscopy: Time-Trend Change After Eradication and Impact of Endoscopic Image Quality. Front Med (Lausanne) (2022) 0.75